Cervical Cancer and the HPV Vaccine. Racial disparifies in cervical cancer in the US are evidenced by higher cervical cancer incidence and mortality rates for 2001-2005 in African American women than non-Hispanic White women (Ries et al., 2008). In Tennessee, during 2001-2005 the cervical cancer incidence was 10.7 per 100,000 for African American women compared to 7.8 per 100,000 for White women (data provided from TN Cancer Registry, 2009). From 1998 to 2003, cervical cancer mortality in Tennessee decreased by 25% among Whites, but increased 22% among African Americans (Whiteside et al., 2007). Persistent infection with high-risk types 16 and 18 of HPV is known to cause 70% of cervical cancers. Since 2006 the FDA has approved two vaccines developed to prevent cervical cancer caused by these high-risk types of genital HPV (Gardasil and Cervarix), which are neariy 100% efficacious in preventing infecfion of HPV types 16 and 18, precancerous cervical disease, and resulfing cervical cancer (FUTURE II Study Group, 2007; Rumbout et al., 2007). In other words, 7 out of 10 new cases of cervical cancer could be prevented bv vaccinating girls before thev become sexually acfive and are exposed to HPV. The Centers for Disease Control and Prevention (CDC, 2007) recommends the HPV vaccines for females ages 11-26 to prevent the majority of cervical cancers for those who are vaccinated before infecfion with one of the high-risk types of HPV. The vaccines (3 doses across six months) are available for free to all giris through age 18 under private insurance, Medicaid and/or the Vaccines for Children (VFC) program. In the 2009 National Immunization Survey, rates of inifiation of the HPV vaccine were similar for African American and white giris (about 44%), but the rate of complefion of the three required doses was lower for African American versus White giris (23% and 29%, respecfively). In Tennessee, 43.6% of adolescents aged 13-17 years had received one or more HPV vaccine doses, similar to the national rate of 44.3% (CDC, 2010).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA163066-02
Application #
8380450
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y)
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
2
Fiscal Year
2012
Total Cost
$83,156
Indirect Cost
$22,551
Name
Tennessee State University
Department
Type
DUNS #
108814179
City
Nashville
State
TN
Country
United States
Zip Code
37209
Massawe, Reda; Drabo, Leon; Whalen, Margaret (2017) Effects of pentachlorophenol and dichlorodiphenyltrichloroethane on secretion of interferon gamma (IFN?) and tumor necrosis factor alpha (TNF?) from human immune cells. Toxicol Mech Methods 27:223-235
Schlundt, David; Briley, Chiquita; Canada, Barbara et al. (2017) Availability of Low-Fat Milk and Produce in Small and Mid-Sized Grocery Stores After 2014 WIC Final Rule Changes, Tennessee. Prev Chronic Dis 14:E70
Amara, Suneetha; Majors, Ciera; Roy, Bipradas et al. (2017) Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation. PLoS One 12:e0180097
Brown, Shyretha; Tehrani, Shahin; Whalen, Margaret M (2017) Dibutyltin-induced alterations of interleukin 1beta secretion from human immune cells. J Appl Toxicol 37:181-191
Amara, Suneetha; Tiriveedhi, Venkataswarup (2017) The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy. Int J Mol Sci 18:
Selove, Rebecca; Foster, Maya; Wujcik, Debra et al. (2017) Psychosocial concerns and needs of cancer survivors treated at a comprehensive cancer center and a community safety net hospital. Support Care Cancer 25:895-904
Martin, Tamara J; Whalen, Margaret M (2017) Exposures to the environmental toxicants pentachlorophenol (PCP) and dichlorodiphenyltrichloroethane (DDT) modify secretion of interleukin 1-beta (IL-1?) from human immune cells. Arch Toxicol 91:1795-1808
Selove, Rebecca; Foster, Maya; Mack, Raquel et al. (2017) Using an Implementation Research Framework to Identify Potential Facilitators and Barriers of an Intervention to Increase HPV Vaccine Uptake. J Public Health Manag Pract 23:e1-e9
Amara, Suneetha; Tiriveedhi, Venkataswarup (2017) Inflammatory role of high salt level in tumor microenvironment (Review). Int J Oncol 50:1477-1481
Husaini, Baqar; Levine, Robert; Lammers, Phillip et al. (2017) Smoking, depression, and hospital costs of respiratory cancers: Examining race and sex variation. Fam Med Community Health 5:29-42

Showing the most recent 10 out of 68 publications